Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Fate Therapeutics Inc (FATE)

Hedge Fund Holdings
Filing Period:
Last update:
No. Hedge Fund Shares Value (x$1000) Activity % Port
1.
Casdin Capital

Eli Casdin

2,550,000 $32,717 5.59%
2.
Redmile Group

Jeremy Green

10,576,363 $135,695 5.45%
3.
Eversept Partners

Kamran Moghtaderi

165,000 $2,117 1.17%
4.
Deerfield Management

James E. Flynn

1,654,865 $21,232 +42% 0.84%
5.
Partner Fund Management

Christopher Medlock James

1,471,000 $18,873 -3% 0.5%
Insider Trading: Purchases See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$13.50 3,703,704 Large Shareholder, Director 10,359,666 2018-09-25 Filing
$2.66 37,593 Officer 37,593 2016-11-23 Filing
$2.66 375,939 Director 459,272 2016-11-23 Filing
$2.66 56,390 Director 56,390 2016-11-23 Filing
$6.00 833,333 Large Shareholder 2,473,187 2013-10-04 Filing
Insider Trading: Sales See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$16.02 4,616 Officer, Director 374,881 2019-04-18 Filing
$16.01 6,843 Officer, Director 374,881 2019-04-18 Filing
$16.18 7,449 Officer, Director 374,881 2019-04-17 Filing
$16.11 1,092 Officer, Director 374,881 2019-04-17 Filing
$16.94 12,500 Officer 135,591 2019-03-28 Filing
Institutional Investors' Holdings
Filing Period:
No. Name Shares Value (x$1000) % Port
1. 80,000 $1,405 0%
2. 1,530 $2,688 0%
3. 190 $333 0%
4. 18,413 $323 0%
5. 430 $8 0%
News See All